Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterActive in the last 2 years

Yuqing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8839-4849; OpenAlex author ID A5111362940. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy. Co-author DOI 10.1158/1078-0432.ccr-24-4368↗
  2. Attenuating DNA damage response and immunosuppression radiosensitizes pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2022.103822↗
  3. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. First author DOI 10.1053/j.gastro.2020.12.077↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Li · 3 shared papers, 2021–2025 · strength 0.67
  2. Courtney W. Houchen · 3 shared papers, 2021–2025 · strength 0.67
  3. Qun Chen · 1 shared paper, 2025 · strength 0.30
  4. Hao Yuan · 1 shared paper, 2025 · strength 0.30
  5. Kuirong Jiang · 1 shared paper, 2025 · strength 0.30
  6. Xiuhui Shi · 1 shared paper, 2021 · strength 0.11
  7. Yuanyuan Jiang · 1 shared paper, 2021 · strength 0.11
  8. Zhijun Zhou · 1 shared paper, 2021 · strength 0.11
  9. Jingxuan Yang · 1 shared paper, 2021 · strength 0.11
  10. Mingyang Liu · 1 shared paper, 2021 · strength 0.11
  11. Hanxiang Zhan · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.